Hepimmune

provided in ready-to-use syringes containing 20 μg/ml of HBsAg including PreS1 and PreS2 adsorbed on aluminium hydroxide (the aluminium content is 0.5 mg/ml); the vaccine was administered intramuscularly into the deltoid region

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results